AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,873 | -50.6% | 65,654 | -14.1% | 0.00% | 0.0% |
| Q2 2023 | $848,008 | -22.2% | 76,466 | +7.7% | 0.00% | -50.0% |
| Q1 2023 | $1,089,528 | -27.4% | 70,979 | +5.0% | 0.00% | 0.0% |
| Q4 2022 | $1,499,778 | +75.4% | 67,588 | +29.1% | 0.00% | +100.0% |
| Q3 2022 | $855,000 | +16.0% | 52,339 | +3.2% | 0.00% | 0.0% |
| Q2 2022 | $737,000 | -13.1% | 50,698 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $848,000 | -27.5% | 45,931 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $1,169,000 | -2.0% | 49,183 | +1.6% | 0.00% | -50.0% |
| Q3 2021 | $1,193,000 | +15.6% | 48,422 | +16.0% | 0.00% | +100.0% |
| Q2 2021 | $1,032,000 | +2.9% | 41,755 | -9.2% | 0.00% | 0.0% |
| Q1 2021 | $1,003,000 | +55.3% | 45,987 | +81.7% | 0.00% | 0.0% |
| Q4 2020 | $646,000 | -9.4% | 25,311 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $713,000 | – | 25,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |